Purpose of the Procedure
- Determining tumor responsiveness to targeted therapies
- Guiding the selection of BRAF and MEK inhibitors
- Providing prognostic information regarding disease progression
Book BRAF V600 Mutation Test | Lahalak Medical Platform
Discover the optimal treatment path with BRAF mutation testing. This molecular analysis helps oncologists determine the effectiveness of targeted therapies and MEK inhibitors for a precise, personalized treatment plan.
Scientific name: BRAF V600 Gene Mutation Molecular Testing
Advanced molecular analysis detecting BRAF gene mutations in tissue or blood samples. It guides targeted therapy decisions for melanoma and colorectal cancer patients for better clinical outcomes.
Service type
Molecular laboratory test
Duration
7-10 working days
Fasting
Fasting is not required
Included Services
- DNA Extraction
- Gene Sequencing Analysis
- Detailed Medical Report
Medical Service Information
Target Groups
- Patients diagnosed with Metastatic Melanoma
- Colorectal cancer patients
- Certain cases of Thyroid or Non-Small Cell Lung Cancer
Clinical Significance
- Positive Result: Indicates mutation presence; patient may benefit from targeted therapy
- Negative Result: No mutation detected; alternative treatment strategies are considered
Conditions & Notices
- Requires a tissue biopsy sample or specific blood sample
- Preferable to provide previous oncology medical reports
Medical services you might also like
